Improving nodal harvest in colorectal cancer: So what?

Annals of Surgical Oncology

Volumn 19, Issue 4, 2012, Pages 1066-1073

  Porter, Geoffrey A ^a,b   Urquhart, Robin ^b   Bu, Jingyu ^b,c   Johnson, Paul ^a   Rayson, Daniel ^a   Grunfeld, Eva ^d,e  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Cancer Outcomes Research Program   (Canada)

^c Surveillance and Epidemiology Unit   (Canada)

^d ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NODAL HARVEST; OUTCOME ASSESSMENT; TRANSPLANTATION;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NOVA SCOTIA; ODDS RATIO; QUALITY INDICATORS, HEALTH CARE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84862495731     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2073-9     Document Type: Article

References (41)

1. Canadian Cancer Society. Cancer Statistics 2010. Toronto, Ontario, Canada: Canadian Cancer Society; November 2010. http://www.cancer.ca/canada- wide/about%20cancer/cancer%20statistics/~/media/CCS/Canada%20wide/Files%20List/ English%20files%20heading/pdf%20not%20in%20publications%20section/ Canadian20Cancer20Statistics2020102020English.ashx. Accessed 20 Dec 2010.
2. Edge SB, Byrd, DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC cancer staging handbook from the AJCC cancer staging manual. 7th ed., New York: Springer; 2010.
3. Chau I, Cunningham D. Adjuvant therapy in colon cancer-what, when and how? Ann Oncol. 2006;17:1347-59. (Pubitemid 44400373)
4. Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22:3408-19. (Pubitemid 41103700)
5. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:979-94. (Pubitemid 30602039)
6. Engstrom PF, Benson AB 3rd, Saltz L, National Comprehensive Cancer Network. Colon cancer: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2003;1:40-53.
7. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol. 2002;26:179-89. (Pubitemid 34127497)
8. Pheby DF, Levine DF, Pitcher RW, Shepherd NA. Lymph node harvests directly influence the staging of colorectal cancer: evidence from a regional audit. J Clin Pathol. 2004;57:43-7. (Pubitemid 38091309)
9. Maurel J, Launoy G, Grosclaude P, Gignoux M, Arveux P, Mathieu-Daudé H, et al. Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer. 1998;82:1482-6. (Pubitemid 28164993)
10. Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol. 1999;17:2896-900. (Pubitemid 29415250)
11. Ratto C, Sofo L, Ippoliti M, Merico M, Bossola M, Vecchio FM, et al. Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum. 1999;42:143-54.
12. Johnson PM, Malatjalian D, Porter GA. Adequacy of nodal harvest in colorectal cancer: a consecutive cohort study. J Gastrointest Surg. 2002;6:883-8.
13. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99:433-41. (Pubitemid 47073566)
14. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of Intergroup trial INT-0089. J Clin Oncol. 2003;21:2912-9. (Pubitemid 46621841)
15. Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 1996;24:3570-5.
16. Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10:65-71.
17. Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006;244:602-10.
18. Jestin P, Pahlman L, Glimelius B, Gunnarsson U. Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination. Eur J Cancer. 2005;41:2071-8. (Pubitemid 41337948)
19. Dillman RO, Aaron K, Heinemann FS, McClure SE. Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance. Cancer. 2009;115:1840-8.
20. Wang J, Kulaylat M, Rockette H, Hassett J, Rajput A, Dunn KB, et al. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer? Ann Surg. 2009;249:559-63.
21. Baxter NN, Ricciardi R, Simunovic M, Urbach DR, Virnig BA. An evaluation of the relationship between lymph node number and staging in pT3 colon cancer using population-based data. Dis Colon Rectum. 2010;53:65-70.
22. Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298:2149-54. (Pubitemid 350106653)
23. National Quality Forum. National Quality Forum Endorsed Standards - colon. http://www.qualityforum.org/Measures-List.aspx?keyword=colon&from= header#k=colon. Accessed 20 Dec 2010.
24. Bosworth T. The ups and downs of pay for performance. Gastroenterol Endosc News. 2006;57:9.
25. Health care quality measures: inventory of performance measures in current use for pay-for-performance. Minnesota Department of Health. www.health.state.mn.us/healthreform/measurement/AppendixB.pdf. Accessed 23 July 2011.
26. Schachter HM, Mamaladze V, Lewin G, Graham ID, Brouwers M, Sampson M, et al. Many quality indicators, but few quality measures assessing the quality of breast cancer care in women: a systematic review. BMC Cancer. 2006;6:291-302.
27. Urquhart R, Grunfeld E. Building tools to measure and improve access to and quality of colorectal cancer care in Nova Scotia. Can J Gastroenterol. 2010;24:91A.
28. Morcos B, Baker B, Al Masri M, Haddad H, Hashem S. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy. Eur J Surg Oncol. 2010;36:345-9.
29. Collaborative Stage Data Collection System. http://www.cancerstaging.org/ cstage/schema/groups.html. Accessed 20 Dec 2010.
30. Porter GA, Urquhart R, Bu J, Johnson P, Grunfeld E. The impact of audit and feedback on nodal harvest in colorectal cancer. BMC Cancer. 2011;11:2.
31. National Quality Forum. NQF in the quality landscape. http://www.qualityforum.org/Setting-Priorities/NQF-in-the-Quality-Landscape. aspx. Accessed 20 Dec 2010.
32. National Quality Forum. National voluntary consensus standards for quality of cancer care. http://www.qualityforum.org/Publications/2009/05/ National-Voluntary-Consensus-Standards-for-Quality-of-Cancer-Care.aspx. Accessed 20 Dec 2010.
33. Cancer Care Ontario. Optimization of surgical and pathological quality performance in radical surgery for colon and rectal cancer: Margins and Lymph Nodes 2008. Toronto, Ontario, Canada: Cancer Care Ontario; 2008. http://www.cancercare.on.ca/cms/one.aspx?portalId=1377&pageId=80771. Accessed 20 Dec 2010.
34. Kukreja SS, Esteban-Agusti E, Velasco JM, Hieken TJ. Increased lymph node evaluation with colorectal cancer resection: Does it improve detection of stage III disease? Arch Surg. 2009;144:612-7.
35. Smith AJ, Law CH, Khalifa MA, Hsieh ET, Hanna SS, Wright FC, et al. Multimodal CME for surgeons and pathologists improves colon cancer staging. J Cancer Educ. 2003;18:81-6.
36. Hernanz F, Revuelta S, Redondo C, Madrazo C, Castillo J, Gomez-Fleitas M. Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum. 1994;37:373-7. (Pubitemid 24132185)
37. Wright FC, Gagliardi AR, Law CH, Last LD, Klevan AE, Hongjinda S, et al. A randomized controlled trial to improve lymph node assessment in stage II colon cancer. Arch Surg. 2008;143:1050-5.
38. Scott KW, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg. 1989;76:1165-7. (Pubitemid 19284443)
39. Cohen SM, Wexner SD, Schmitt SL, Nogueras JJ, Lucas FV. Effect of xylene clearance of mesenteric fat on harvest of lymph nodes after colonic resection. Eur J Surg. 1994;160:693-7. (Pubitemid 24380863)
40. Iversen LH, Laurberg S, Hagemann-Madsen R, Dybdahl H. Increased lymph node harvest from colorectal cancer resections using GEWF solution: a randomised study. J Clin Pathol. 2008;61:1203-8.
41. Robinson CN, Chen GJ, Balentine CJ, Sansgiry S, Marshall CL, Anaya DA, et al. Minimally invasive surgery is underutilized for colon cancer. Ann Surg Oncol. 2011;18:1412-8.